126 related articles for article (PubMed ID: 35904158)
1. Critical reagent inventory management system and web portal specifically optimized for supporting external clients.
Feauto JA; Davis A; Delhaye RC; Abdeen SJ; Gill HN; Colwell JE; Chiappetta M; Clor EE; Bowsher RR
Bioanalysis; 2022 Jun; 14(12):869-879. PubMed ID: 35904158
[TBL] [Abstract][Full Text] [Related]
2. Ligand binding assay critical reagents and their stability: recommendations and best practices from the Global Bioanalysis Consortium Harmonization Team.
King LE; Farley E; Imazato M; Keefe J; Khan M; Ma M; Pihl KS; Sriraman P
AAPS J; 2014 May; 16(3):504-15. PubMed ID: 24687208
[TBL] [Abstract][Full Text] [Related]
3. Adventures in critical reagent lot changes in ligand-binding assays: redevelopment, bridging and additional processing requirements.
Rauwerdink A; Benson M; Jayne A; Babu S; St Charles J; Smith A
Bioanalysis; 2021 May; 13(10):771-777. PubMed ID: 33884890
[No Abstract] [Full Text] [Related]
4. Ligand binding assays in the 21st century laboratory: recommendations for characterization and supply of critical reagents.
O'Hara DM; Theobald V; Egan AC; Usansky J; Krishna M; TerWee J; Maia M; Spriggs FP; Kenney J; Safavi A; Keefe J
AAPS J; 2012 Jun; 14(2):316-28. PubMed ID: 22415613
[TBL] [Abstract][Full Text] [Related]
5. EBF recommendation on practical management of critical reagents for PK ligand-binding assays.
Pihl S; van der Strate BW; Golob M; Vermet L; Jaitner B; Goodman J; Fjording MS; Timmerman P
Bioanalysis; 2018 Oct; 10(19):1557-1565. PubMed ID: 30226086
[TBL] [Abstract][Full Text] [Related]
6. Life cycle management of critical ligand-binding reagents.
O'Hara DM; Theobald V
Bioanalysis; 2013 Nov; 5(21):2679-96. PubMed ID: 24180507
[TBL] [Abstract][Full Text] [Related]
7. Critical reagents for ligand-binding assays: process development methodologies to enable high-quality reagents.
Kittinger C; Delmar J; Hewitt L; Holcomb R; Jones C; Jones H; Kubiak R; Lee N; McClenny LC; Mody N; O'Connor E
Bioanalysis; 2022 Feb; 14(3):117-135. PubMed ID: 35019733
[TBL] [Abstract][Full Text] [Related]
8. Surface plasmon resonance as a tool for ligand-binding assay reagent characterization in bioanalysis of biotherapeutics.
Duo J; Bruno J; Kozhich A; David-Brown D; Luo L; Kwok S; Santockyte R; Haulenbeek J; Liu R; Hamuro L; Peterson JE; Piccoli S; DeSilva B; Pillutla R; Zhang YJ
Bioanalysis; 2018 Apr; 10(8):559-576. PubMed ID: 29701071
[TBL] [Abstract][Full Text] [Related]
9. Critical reagent generation, characterization, handling and storage workflows: impact on ligand binding assays.
Oquendo E; Savoie J; Swenson JM; Grimaldi C
Bioanalysis; 2021 May; 13(10):847-860. PubMed ID: 33890503
[TBL] [Abstract][Full Text] [Related]
10. Sponsor relationships, analyte stability in ligand-binding assays and critical reagent management: a bioanalytical CRO perspective.
Lefor Bradford J
Bioanalysis; 2015; 7(11):1337-46. PubMed ID: 26110706
[TBL] [Abstract][Full Text] [Related]
11. Quality requirements for critical assay reagents used in bioanalysis of therapeutic proteins: what bioanalysts should know about their reagents.
Staack RF; Stracke JO; Stubenrauch K; Vogel R; Schleypen J; Papadimitriou A
Bioanalysis; 2011 Mar; 3(5):523-34. PubMed ID: 21388265
[TBL] [Abstract][Full Text] [Related]
12. Critical ligand binding reagent preparation/selection: when specificity depends on reagents.
Rup B; O'Hara D
AAPS J; 2007 May; 9(2):E148-55. PubMed ID: 17614357
[TBL] [Abstract][Full Text] [Related]
13. Characterization of critical reagents in ligand-binding assays: enabling robust bioanalytical methods and lifecycle management.
Geist BJ; Egan AC; Yang TY; Dong Y; Shankar G
Bioanalysis; 2013 Jan; 5(2):227-44. PubMed ID: 23330563
[TBL] [Abstract][Full Text] [Related]
14. The impact of ligand binding based assays critical reagent characterization and storage.
Haulenbeek J; Beaver CJ
Bioanalysis; 2021 May; 13(10):797-805. PubMed ID: 34002637
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical Reagent Inventory Strategy Based on Contract Shelf Life and Patient Demand.
Li L; Liu Z; Qian Q; Zhao Z; Zhao Y
Contrast Media Mol Imaging; 2022; 2022():5046141. PubMed ID: 35542757
[TBL] [Abstract][Full Text] [Related]
16. Quality Controls in Ligand Binding Assays: Recommendations and Best Practices for Preparation, Qualification, Maintenance of Lot to Lot Consistency, and Prevention of Assay Drift.
Azadeh M; Sondag P; Wang Y; Raines M; Sailstad J
AAPS J; 2019 Jul; 21(5):89. PubMed ID: 31297703
[TBL] [Abstract][Full Text] [Related]
17. 2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 - Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62).
Piccoli S; Mehta D; Vitaliti A; Allinson J; Amur S; Eck S; Green C; Hedrick M; Hopper S; Ji A; Joyce A; Litwin V; Maher K; Mathews J; Peng K; Safavi A; Wang YM; Zhang Y; Amaravadi L; Palackal N; Thankamony S; Beaver C; Bame E; Emrich T; Grimaldi C; Haulenbeek J; Joyce A; Kakkanaiah V; Lanham D; Maher K; Mayer A; Trampont PC; Vermet L; Dakappagari N; Fleener C; Garofolo F; Rogers C; Tangri S; Xu Y; Liang M; Rajadhyaksha M; Richards S; Schweighardt B; Purushothama S; Baltrukonis D; Brumm J; Cherry E; Delcarpini J; Gleason C; Kirshner S; Kubiak R; Pan L; Partridge M; Pedras-Vasconcelos J; Qu Q; Skibeli V; Saunders TS; Staack RF; Stubenrauch K; Torri A; Verthelyi D; Yan H; Gorovits B; Palmer R; Milton M; Long B; Corsaro B; Farrokhi V; Fiscella M; Henderson N; Jawa V; McNally J; Murphy R; Waldner H; Yang TY
Bioanalysis; 2019 Dec; 11(24):2207-2244. PubMed ID: 31820675
[TBL] [Abstract][Full Text] [Related]
18. Current and effective strategies for critical reagent characterization, storage, stability, retesting and life cycle management for ligand-binding assays and flow cytometry.
Amaravadi L; Palackal N; Garofolo F
Bioanalysis; 2021 May; 13(10):737-740. PubMed ID: 34037426
[No Abstract] [Full Text] [Related]
19. Critical reagent characterization and re-evaluation to ensure long-term stability: two case studies.
Caiazzo TM; Shea CM; Joyce AP
Bioanalysis; 2021 May; 13(10):807-815. PubMed ID: 33884894
[TBL] [Abstract][Full Text] [Related]
20. The importance of quality critical reagents for the entire developmental lifecycle of a biopharmaceutical: a pharmacokinetic case study.
Mayer AP; Fraley KJ
Bioanalysis; 2021 May; 13(10):817-827. PubMed ID: 33769084
[No Abstract] [Full Text] [Related]
[Next] [New Search]
